[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Sino Biopharmaceutical Limited Graphic Sino Biopharmaceutical Limited

Sino Biopharmaceutical is acquiring LaNova Medicines for up to $XXX million, leading to positive sentiment and price increases. The acquisition is expanding its oncology capabilities and global reach.

About Sino Biopharmaceutical Limited

Sino Biopharmaceutical Limited is a pharmaceutical company.

Insights #

Price: $ #


Price Line Chart
Price 24-Hour Chart Data
The price is rising, hitting a daily high of $XXXX and a 1-year high of $6.90, likely due to increased social media engagement, positive analyst comments, the COVID-19 wave in Asia, and the acquisition of LaNova Medicines.

1-Year High: $XXXX on 2025-07-18
1-Year Low: $XXXX on 2024-07-30

AltRank: undefined #


AltRank Line Chart
AltRank 24-Hour Chart Data
Sino Biopharmaceutical Limited is currently AltRank #undefined based on combined combined social and market metrics Daily Average: XXXXX
1-Year High: XXXXX on 2025-01-03
1-Year Low: XXX on 2025-02-27

Galaxy Score: XX #


Galaxy Score Line Chart
Galaxy Score 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2025-07-16
1-Year Low: XX on 2025-07-18

Engagements: XXX #


Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XXX
Daily Average: XXXXX
1 Week: XXXXX -XX%
1 Month: XXXXXX +64,472%
1-Year High: XXXXXX on 2025-07-15
1-Year Low: X on 2025-02-24

Social Network X News YouTube
Engagements XXX XX X

Mentions: XX #


Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: X
1 Week: XX +39%
1 Month: XX +383%
1-Year High: XX on 2025-07-18
1-Year Low: X on 2025-02-24

Social Network X News YouTube
Mentions XX X X

Creators: XX #


Creators Line Chart
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning Sino Biopharmaceutical Limited in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: X
1 Week: XX +46%
1 Month: XX +267%
1-Year High: XX on 2025-07-18
1-Year Low: X on 2025-02-24

Sentiment: XXX% #


Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XXX%
Daily Average: XX%
1 Week: XXX% no change
1-Year High: XXX% on 2025-07-15
1-Year Low: XX% on 2025-07-07

Most Supportive Themes

Most Critical Themes

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XX XX% XXX XX% X X%
News X X% XX XX% X X%
YouTube X X% X X% X X%
Total XX XX% XXX XX% X X%

Market Cap: $undefined #


Market Cap Line Chart
Market Cap 24-Hour Chart Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXXX on 2024-10-04
1-Year Low: $XXXXXXXXXXXXXX on 2025-02-11

Top assets mentioned In the posts about Sino Biopharmaceutical Limited in the last XX hours

Merck & Co., Inc. (MRK)

Top topics mentioned In the posts about Sino Biopharmaceutical Limited in the last XX hours

china, acquisition, $951m, han, $4507t, stocks, pfe, $bntx, $588m, investment, $mrk, stocks healthcare, web3, iran, hodl, #crypto, #bitcoin, capabilities, $500m, networks, Sentiment, $950m, preorder, $2015hk, $9688hk, $2359hk, $2269hk, $1801hk, ist, von, spa

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Han Kun Law Offices and @zhonglunlawfirm have taken lead legal roles in a China acquisition where Sino Biopharmaceutical acquires LaNova Medicines for up to USD950 million. See more in @CBLJ_insights. #cblj #china #capitalmarkets #lawfirms #lawyers #law"
@CBLJ_insights on X 2025-07-23 08:00:00 UTC XXX followers, X engagements

"Han Kun Law Offices and Zhong Lun Law Firm have taken lead legal roles in a China acquisition where drug giant Sino Biopharmaceutical acquires cancer treatment manufacturer LaNova Medicines for up to USD950 million. Read more 👇 #cblj #china #investment"
@CBLJ_insights on X 2025-07-21 06:00:34 UTC XXX followers, XX engagements

"HSI -XXX% Beijing targets irrational competition in EV market $175.HK +4% merge with Zeekr $2015.HK +10% starts new pre-order of SUV model $1177.HK +5% will buy remaining XX% stake in LaNova medicine for $950m; signalling first China to China M&A for the pharma sector"
@vinhtk5 on X 2025-07-17 09:48:38 UTC X followers, XX engagements